Rimsys Introduces a Community-Driven Regulatory Intelligence Platform

Monday, May 06, 2024

Rimsys, a leading provider of regulatory information management software for the medical technology industry, has announced the beta launch of Rimsys Intel.

This platform is a community-driven hub for global regulatory intelligence data, aiming to increase the accessibility of life-changing medical technologies by offering users free access to regulatory insights.

The company's commitment to empowering medtech teams by providing easily accessible and free regulatory intelligence. Rimsys Intel offers information on regulatory affiliations, legislation updates, UDI requirements, risk class data for medical devices and IVDs, and market access requirements for different countries.

To ensure the accuracy and relevance of Rimsys Intel amidst evolving global regulations, Rimsys is collaborating with RAPS Regulatory Affairs Certificate (RAC) holders.

RAC holders, who demonstrate proficiency in medical device and pharmaceutical regulations, can earn recertification credits by engaging with and reviewing Rimsys Intel data.

Collaboration with RAC holders, emphasizing its benefits for both the medtech community and professional development.

Rimsys Intel is currently available to a limited number of beta users, with general availability expected later this year. Interested individuals can sign up for the beta waitlist to access Rimsys Intel.






Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare CNO Summit - USAHealthcare CMO Summit - USAHealthcare CFO, Financial Strategy & Revenue Cycle SummitHealthcare CEO & Executive Strategy Summit